{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:53:06Z","timestamp":1794513186518,"version":"4.9.1"},"reference-count":226,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Cardiovascular disorders (CVDs) are reported to occur with very high rates of incidence\nand exhibit high morbidity and mortality rates across the globe. Therefore, research is focused\non searching for novel therapeutic targets involving multiple pathophysiological mechanisms.\nOxidative stress plays a critical role in the development and progression of various CVDs,\nsuch as hypertension, pulmonary hypertension, heart failure, arrhythmia, atherosclerosis, ischemia-\nreperfusion injury, and myocardial infarction. Among multiple pathways generating reactive\noxygen species (ROS), Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases of the\nNOX family as the major source of ROS generation and plays an intricate role in the development\nand progression of CVDs. Therefore, exploring the role of different NADPH oxidase isoforms in\nvarious cardiovascular pathologies has attracted attention to current cardiovascular research. Focusing\non NADPH oxidases to reduce oxidative stress in managing diverse CVDs may offer\nunique therapeutic approaches to prevent and treat various heart conditions. The current review article\nhighlights the role of different NADPH oxidase isoforms in the pathophysiology of various\nCVDs. Moreover, the focus is also to emphasize different experimental studies that utilized various\nNADPH oxidase isoform modulators to manage other disorders. The present review article\nconsiders new avenues for researchers\/scientists working in the field of cardiovascular pharmacology\nutilizing NADPH oxidase isoform modulators.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115701611308870240910115023","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T12:19:43Z","timestamp":1727266783000},"page":"12-30","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Delineating the NOX-Mediated Promising Therapeutic Strategies for the Management of Various Cardiovascular Disorders: A Comprehensive Review"],"prefix":"10.2174","volume":"23","author":[{"given":"Rohit Kumar","family":"Upadhyay","sequence":"first","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuldeep","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Kumar","family":"Vishwakarma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of\nPharmaceutical Sciences and Drug Research, Punjabi University, Patiala, (Punjab)-147002-India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Narang","sequence":"additional","affiliation":[{"name":"Department of\nCardiology, All India Institute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeraj","family":"Parakh","sequence":"additional","affiliation":[{"name":"Department of\nCardiology, All India Institute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of CTVS, All India\nInstitute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Dr. B.R. Ambedkar Centre for\nBiomedical Research, New Delhi, 110085-India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Technology, School of Allied\nHealth Sciences, Delhi Pharmaceutical Sciences and Research University, Pushp Vihar, New Delhi, 110017, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsas","family":"Goyal","sequence":"additional","affiliation":[{"name":"Institute of Pharmaceutical Research, GLA University, Mathura, 280406, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harlokesh Narayan","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, 110029, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.3390\/biomedicines10081938","volume":"10","author":"Fr\u0105k W.","year":"2022","unstructured":"Fr\u0105k W.; Wojtasi\u0144ska A.; Lisi\u0144ska W.; M\u0142ynarska E.; Franczyk B.; Rysz J.; Pathophysiology of cardiovascular diseases: New insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease. Biomedicines  2022,10(8),1938","journal-title":"Biomedicines"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/nu11092090","volume":"11","author":"Senoner T.","year":"2019","unstructured":"Senoner T.; Dichtl W.; Oxidative stress in cardiovascular diseases: Still a therapeutic target? Nutrients  2019,11(9),2090","journal-title":"Nutrients"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"9420539","DOI":"10.1155\/2017\/9420539","volume":"2017","author":"Skonieczna M.","year":"2017","unstructured":"Skonieczna M.; Hejmo T.; Poterala-Hejmo A.; Cieslar-Pobuda A.; Buldak R.J.; NADPH oxidases: Insights into selected functions and mechanisms of action in cancer and stem cells. Oxid Med Cell Longev  2017,2017(1),9420539","journal-title":"Oxid Med Cell Longev"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1089\/ars.2012.4641","volume":"19","author":"Nguyen Dinh Cat A.","year":"2013","unstructured":"Nguyen Dinh Cat A.; Montezano A.C.; Burger D.; Touyz R.M.; Angiotensin I.I.; Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal  2013,19(10),1110-1120","journal-title":"Antioxid Redox Signal"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"Bedard K.","year":"2007","unstructured":"Bedard K.; Krause K.H.; The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev  2007,87(1),245-313","journal-title":"Physiol Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1042\/CS20140542","volume":"182","author":"Roy K","year":"2015","unstructured":"Roy K; Wu Y; Meitzler JL; Juhasz A; Liu H; Jiang G; NADPH oxidases and cancer. Clin Sci Lond Engl 1979  2015,182(12),863-75","journal-title":"Clin Sci Lond Engl 1979"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri1312","volume":"4","author":"Lambeth J.D.","year":"2004","unstructured":"Lambeth J.D.; NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol  2004,4(3),181-189","journal-title":"Nat Rev Immunol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1089\/ars.2012.4550","volume":"18","author":"Zhang M.","year":"2013","unstructured":"Zhang M.; Perino A.; Ghigo A.; Hirsch E.; Shah A.M.; NADPH oxidases in heart failure: Poachers or gamekeepers? Antioxid Redox Signal  2013,18(9),1024-1041","journal-title":"Antioxid Redox Signal"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1042\/CS20150087","volume":"130","author":"Sahoo S","year":"2016","unstructured":"Sahoo S; Meijles DN; Pagano PJ; NADPH oxidases in heart failure: Poachers or gamekeepers? Clin Sci Lond Engl 1979  2016,130(5),317-35","journal-title":"Clin Sci Lond Engl 1979"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MOL.0b013e32830c91e3","volume":"19","author":"Brandes R.P.","year":"2008","unstructured":"Brandes R.P.; Schr\u00f6der K.; Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol  2008,19(5),513-518","journal-title":"Curr Opin Lipidol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1089\/ars.2009.2637","volume":"11","author":"Leto T.L.","year":"2009","unstructured":"Leto T.L.; Morand S.; Hurt D.; Ueyama T.; Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal  2009,11(10),2607-2619","journal-title":"Antioxid Redox Signal"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"Mittal M.","year":"2014","unstructured":"Mittal M.; Siddiqui M.R.; Tran K.; Reddy S.P.; Malik A.B.; Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal  2014,20(7),1126-1167","journal-title":"Antioxid Redox Signal"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"R277","DOI":"10.1152\/ajpregu.00758.2002","volume":"285","author":"Lass\u00e8gue B.","year":"2003","unstructured":"Lass\u00e8gue B.; Clempus R.E.; Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol  2003,285(2),R277-R297","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/152308603770380115","volume":"5","author":"Brandes R.P.","year":"2003","unstructured":"Brandes R.P.; Role of NADPH oxidases in the control of vascular gene expression. Antioxid Redox Signal  2003,5(6),803-811","journal-title":"Antioxid Redox Signal"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1089\/ars.2006.8.1473","volume":"8","author":"Petry A.","year":"2006","unstructured":"Petry A.; Djordjevic T.; Weitnauer M.; Kietzmann T.; Hess J.; G\u00f6rlach A.; NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal  2006,8(9-10),1473-1484","journal-title":"Antioxid Redox Signal"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/43459","volume":"401","author":"Suh Y.A.","year":"1999","unstructured":"Suh Y.A.; Arnold R.S.; Lassegue B.; Shi J.; Xu X.; Sorescu D.; Chung A.B.; Griendling K.K.; Lambeth J.D.; Cell transformation by the superoxide-generating oxidase Mox1. Nature  1999,401(6748),79-82","journal-title":"Nature"},{"key":"ref=17","first-page":"1225","volume":"33","author":"Di Wang H","year":"1999","unstructured":"Di Wang H; Hope S; Du Y; Quinn MT; Cayatte A; Pagano PJ; Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertens Dallas Tex 1979  1999,33(5),1225-32","journal-title":"Hypertens Dallas Tex 1979"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"14483","DOI":"10.1073\/pnas.94.26.14483","volume":"94","author":"Pagano P.J.","year":"1997","unstructured":"Pagano P.J.; Clark J.K.; Cifuentes-Pagano M.E.; Clark S.M.; Callis G.M.; Quinn M.T.; Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: Enhancement by angiotensin II. Proc Natl Acad Sci USA  1997,94(26),14483-14488","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"37594","DOI":"10.1074\/jbc.M103034200","volume":"276","author":"B\u00e1nfi B.","year":"2001","unstructured":"B\u00e1nfi B.; Moln\u00e1r G.; Maturana A.; Steger K.; Heged\u00fbs B.; Demaurex N.; Krause K.H.; A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem  2001,276(40),37594-37601","journal-title":"J Biol Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1089\/ars.2006.8.691","volume":"8","author":"Cave A.C.","year":"2006","unstructured":"Cave A.C.; Brewer A.C.; Narayanapanicker A.; Ray R.; Grieve D.J.; Walker S.; Shah A.M.; NADPH oxidases in cardiovascular health and disease. Antioxid Redox Signal  2006,8(5-6),691-728","journal-title":"Antioxid Redox Signal"},{"key":"ref=21","first-page":"1","volume":"57","author":"Warburg O.","year":"1908","unstructured":"Warburg O.;  Beobachtungen \u00fcber die Oxydationsprozesse im Seeigelei  1908,57(1\u20132),1-16","journal-title":"Beobachtungen \u00fcber die Oxydationsprozesse im Seeigelei"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1152\/ajplegacy.1932.103.1.235","volume":"103","author":"Baldridge C.W.","year":"1932","unstructured":"Baldridge C.W.; Gerard R.W.; The extra respiration of phagocytosis. Am J Physiol  1932,103(1),235-236","journal-title":"Am J Physiol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/S0021-9258(18)70011-2","volume":"234","author":"Sbarra A.J.","year":"1959","unstructured":"Sbarra A.J.; Karnovsky M.L.; The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem  1959,234(6),1355-1362","journal-title":"J Biol Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/192535a0","volume":"192","author":"Iyer G.Y.N.","year":"1961","unstructured":"Iyer G.Y.N.; Islam M.F.; Quastel J.H.; Biochemical aspects of phagocytosis. Nature  1961,192(4802),535-541","journal-title":"Nature"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF02146019","volume":"20","author":"Rossi F.","year":"1964","unstructured":"Rossi F.; Zatti M.; Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia  1964,20(1),21-23","journal-title":"Experientia"},{"key":"ref=26","first-page":"548","volume":"45","author":"Rossi F.","year":"1964","unstructured":"Rossi F.; Zatti M.; Changes in the metabolic pattern of polymorpho-nuclear leucocytes during phagocytosis. Br J Exp Pathol  1964,45(5),548-559","journal-title":"Br J Exp Pathol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1172\/JCI105568","volume":"46","author":"Quie P.G.","year":"1967","unstructured":"Quie P.G.; White J.G.; Holmes B.; Good R.A.; In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood. J Clin Invest  1967,46(4),668-679","journal-title":"J Clin Invest"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1126\/science.155.3764.835","volume":"155","author":"Baehner R.L.","year":"1967","unstructured":"Baehner R.L.; Nathan D.G.; Leukocyte oxidase: Defective activity in chronic granulomatous disease. Science  1967,155(3764),835-836","journal-title":"Science"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1172\/JCI105634","volume":"46","author":"Holmes B.","year":"1967","unstructured":"Holmes B.; Page A.R.; Good R.A.; Studies of the metabolic activity of leukocytes from patients with a genetic abnormality of phagocytic function. J Clin Invest  1967,46(9),1422-1432","journal-title":"J Clin Invest"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1172\/JCI107236","volume":"52","author":"Babior B.M.","year":"1973","unstructured":"Babior B.M.; Kipnes R.S.; Curnutte J.T.; Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest  1973,52(3),741-744","journal-title":"J Clin Invest"},{"key":"ref=31","first-page":"117","volume":"12","author":"Klebanoff S.J.","year":"1975","unstructured":"Klebanoff S.J.; Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol  1975,12(2),117-142","journal-title":"Semin Hematol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1056\/NEJM197803232981205","volume":"298","author":"Babior B.M.","year":"1978","unstructured":"Babior B.M.; Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med  1978,298(12),659-668","journal-title":"N Engl J Med"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/276515a0","volume":"276","author":"Segal A.W.","year":"1978","unstructured":"Segal A.W.; Jones O.T.G.; Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature  1978,276(5687),515-517","journal-title":"Nature"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1042\/bj2230337","volume":"223","author":"Cross A.R.","year":"1984","unstructured":"Cross A.R.; Parkinson J.F.; Jones O.T.G.; The superoxide-generating oxidase of leucocytes. NADPH-dependent reduction of flavin and cytochrome b in solubilized preparations. Biochem J  1984,223(2),337-344","journal-title":"Biochem J"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/327717a0","volume":"327","author":"Dinauer M.C.","year":"1987","unstructured":"Dinauer M.C.; Orkin S.H.; Brown R.; Jesaitis A.J.; Parkos C.A.; The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature  1987,327(6124),717-720","journal-title":"Nature"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1172\/JCI113128","volume":"80","author":"Parkos C.A.","year":"1987","unstructured":"Parkos C.A.; Allen R.A.; Cochrane C.G.; Jesaitis A.J.; Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest  1987,80(3),732-742","journal-title":"J Clin Invest"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/327720a0","volume":"327","author":"Teahan C.","year":"1987","unstructured":"Teahan C.; Rowe P.; Parker P.; Totty N.; Segal A.W.; The X-linked chronic granulomatous disease gene codes for the \u03b2-chain of cytochrome b\u2212245. Nature  1987,327(6124),720-721","journal-title":"Nature"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1046\/j.1365-313X.1996.10030515.x","volume":"10","author":"Groom Q.J.","year":"1996","unstructured":"Groom Q.J.; Torres M.A.; Fordham-Skelton A.P.; Hammond-Kosack K.E.; Robinson N.J.; Jones J.D.G.; rbohA, a rice homologue of the mammalian gp91phox respiratory burst oxidase gene. Plant J  1996,10(3),515-522","journal-title":"Plant J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"37265","DOI":"10.1074\/jbc.274.52.37265","volume":"274","author":"Dupuy C.","year":"1999","unstructured":"Dupuy C.; Ohayon R.; Valent A.; No\u00ebl-Hudson M.S.; D\u00e8me D.; Virion A.; Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas. J Biol Chem  1999,274(52),37265-37269","journal-title":"J Biol Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"23227","DOI":"10.1074\/jbc.M000916200","volume":"275","author":"De Deken X.","year":"2000","unstructured":"De Deken X.; Wang D.; Many M.C.; Costagliola S.; Libert F.; Vassart G.; Dumont J.E.; Miot F.; Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem  2000,275(30),23227-23233","journal-title":"J Biol Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e01487-17","DOI":"10.1128\/mBio.01487-17","volume":"8","author":"Hajjar C.","year":"2017","unstructured":"Hajjar C.; Cherrier M.V.; Dias Mirandela G.; Petit-Hartlein I.; Stasia M.J.; Fontecilla-Camps J.C.; Fieschi F.; Dupuy J.; The NOX family of proteins is also present in bacteria. MBio  2017,8(6),e01487-17","journal-title":"MBio"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"6764","DOI":"10.1073\/pnas.1702293114","volume":"114","author":"Magnani F.","year":"2017","unstructured":"Magnani F.; Nenci S.; Millana Fananas E.; Ceccon M.; Romero E.; Fraaije M.W.; Mattevi A.; Crystal structures and atomic model of NADPH oxidase. Proc Natl Acad Sci USA  2017,114(26),6764-6769","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"890","DOI":"10.3390\/antiox10060890","volume":"10","author":"Vermot A.","year":"2021","unstructured":"Vermot A.; Petit-H\u00e4rtlein I.; Smith S.M.E.; Fieschi F.; NADPH oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants  2021,10(6),890","journal-title":"Antioxidants"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1126\/science.287.5450.138","volume":"287","author":"B\u00e1nfi B.","year":"2000","unstructured":"B\u00e1nfi B.; Maturana A.; Jaconi S.; Arnaudeau S.; Laforge T.; Sinha B.; Ligeti E.; Demaurex N.; Krause K.H.; A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science  2000,287(5450),138-142","journal-title":"Science"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1089\/ars.2008.2383","volume":"11","author":"Helmcke I.","year":"2009","unstructured":"Helmcke I.; Heum\u00fcller S.; Tikkanen R.; Schr\u00f6der K.; Brandes R.P.; Identification of structural elements in Nox1 and Nox4 controlling localization and activity. Antioxid Redox Signal  2009,11(6),1279-1287","journal-title":"Antioxid Redox Signal"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1074\/jbc.M305968200","volume":"279","author":"Cheng G.","year":"2004","unstructured":"Cheng G.; Lambeth J.D.; NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem  2004,279(6),4737-4742","journal-title":"J Biol Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/01.ATV.0000112024.13727.2c","volume":"24","author":"Hilenski L.L.","year":"2004","unstructured":"Hilenski L.L.; Clempus R.E.; Quinn M.T.; Lambeth J.D.; Griendling K.K.; Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol  2004,24(4),677-683","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"45935","DOI":"10.1074\/jbc.M406486200","volume":"279","author":"Ambasta R.K.","year":"2004","unstructured":"Ambasta R.K.; Kumar P.; Griendling K.K.; Schmidt H.H.H.W.; Busse R.; Brandes R.P.; Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase. J Biol Chem  2004,279(44),45935-45941","journal-title":"J Biol Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1038\/sj.onc.1206654","volume":"22","author":"Chamulitrat W.","year":"2003","unstructured":"Chamulitrat W.; Schmidt R.; Tomakidi P.; Stremmel W.; Chunglok W.; Kawahara T.; Rokutan K.; Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene  2003,22(38),6045-6053","journal-title":"Oncogene"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4161\/cbt.4.12.2233","volume":"4","author":"Desouki M.M.","year":"2005","unstructured":"Desouki M.M.; Kulawiec M.; Bansal S.; Das G.C.; Singh K.K.; Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther  2005,4(12),1367-1373","journal-title":"Cancer Biol Ther"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1073\/pnas.022630199","volume":"99","author":"Arbiser J.L.","year":"2002","unstructured":"Arbiser J.L.; Petros J.; Klafter R.; Govindajaran B.; McLaughlin E.R.; Brown L.F.; Cohen C.; Moses M.; Kilroy S.; Arnold R.S.; Lambeth J.D.; Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc Natl Acad Sci USA  2002,99(2),715-720","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/01.mnh.0000214776.19233.68","volume":"15","author":"Cifuentes M.E.","year":"2006","unstructured":"Cifuentes M.E.; Pagano P.J.; Targeting reactive oxygen species in hypertension. Curr Opin Nephrol Hypertens  2006,15(2),179-186","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00281-008-0117-4","volume":"30","author":"Nauseef W.M.","year":"2008","unstructured":"Nauseef W.M.; Nox enzymes in immune cells. Semin Immunopathol  2008,30(3),195-208","journal-title":"Semin Immunopathol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1161\/01.ATV.0000196651.64776.51","volume":"26","author":"Guzik T.J.","year":"2006","unstructured":"Guzik T.J.; Sadowski J.; Guzik B.; Jopek A.; Kapelak B.; Przyby\u0142owski P.; Wierzbicki K.; Korbut R.; Harrison D.G.; Channon K.M.; Coronary artery superoxide production and nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol  2006,26(2),333-339","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/01.ATV.0000139011.94634.9d","volume":"24","author":"Guzik T.J.","year":"2004","unstructured":"Guzik T.J.; Sadowski J.; Kapelak B.; Jopek A.; Rudzinski P.; Pillai R.; Korbut R.; Channon K.M.; Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol  2004,24(9),1614-1620","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1089\/ars.2006.8.1583","volume":"8","author":"Infanger D.W.","year":"2006","unstructured":"Infanger D.W.; Sharma R.V.; Davisson R.L.; NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid Redox Signal  2006,8(9-10),1583-1596","journal-title":"Antioxid Redox Signal"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/ars.2005.7.308","volume":"7","author":"Buul J.D.V.","year":"2005","unstructured":"Buul J.D.V.; Fernandez-Borja M.; Anthony E.C.; Hordijk P.L.; Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal  2005,7(3-4),308-317","journal-title":"Antioxid Redox Signal"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.2337\/dc08-s247","volume":"31","author":"Paravicini T.M.","year":"2008","unstructured":"Paravicini T.M.; Touyz R.M.; NADPH oxidases, reactive oxygen species, and hypertension: Clinical implications and therapeutic possibilities. Diabetes Care  2008,31(Suppl. 2),S170-S180","journal-title":"Diabetes Care"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1083\/jcb.97.1.52","volume":"97","author":"Borregaard N.","year":"1983","unstructured":"Borregaard N.; Heiple J.M.; Simons E.R.; Clark R.A.; Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: Translocation during activation. J Cell Biol  1983,97(1),52-61","journal-title":"J Cell Biol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2011.12.025","volume":"519","author":"Kawano M.","year":"2012","unstructured":"Kawano M.; Miyamoto K.; Kaito Y.; Sumimoto H.; Tamura M.; Noxa1 as a moderate activator of Nox2-based NADPH oxidase. Arch Biochem Biophys  2012,519(1),1-7","journal-title":"Arch Biochem Biophys"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"23317","DOI":"10.1074\/jbc.271.38.23317","volume":"271","author":"Ushio-Fukai M.","year":"1996","unstructured":"Ushio-Fukai M.; Zafari A.M.; Fukui T.; Ishizaka N.; Griendling K.K.; p22phox is a critical component of the superoxide-generating NADH\/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem  1996,271(38),23317-23321","journal-title":"J Biol Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"8010","DOI":"10.1073\/pnas.130135897","volume":"97","author":"Geiszt M.","year":"2000","unstructured":"Geiszt M.; Kopp J.B.; V\u00e1rnai P.; Leto T.L.; Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA  2000,97(14),8010-8014","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1089\/ars.2009.2561","volume":"11","author":"Goettsch C.","year":"2009","unstructured":"Goettsch C.; Goettsch W.; Arsov A.; Hofbauer L.C.; Bornstein S.R.; Morawietz H.; Long-term cyclic strain downregulates endothelial Nox4. Antioxid Redox Signal  2009,11(10),2385-2397","journal-title":"Antioxid Redox Signal"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bbrc.2009.01.107","volume":"380","author":"Goettsch C.","year":"2009","unstructured":"Goettsch C.; Goettsch W.; Muller G.; Seebach J.; Schnittler H.J.; Morawietz H.; Nox4 overexpression activates reactive oxygen species and p38 MAPK in human endothelial cells. Biochem Biophys Res Commun  2009,380(2),355-360","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1161\/01.CIR.0000012917.74432.66","volume":"105","author":"Sorescu D.","year":"2002","unstructured":"Sorescu D.; Weiss D.; Lass\u00e8gue B.; Clempus R.E.; Sz\u00f6cs K.; Sorescu G.P.; Valppu L.; Quinn M.T.; Lambeth J.D.; Vega J.D.; Taylor W.R.; Griendling K.K.; Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation  2002,105(12),1429-1435","journal-title":"Circulation"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1128\/MCB.24.24.10703-10717.2004","volume":"24","author":"Pedruzzi E.","year":"2004","unstructured":"Pedruzzi E.; Guichard C.; Ollivier V.; Driss F.; Fay M.; Prunet C.; Marie J.C.; Pouzet C.; Samadi M.; Elbim C.; O\u2019Dowd Y.; Bens M.; Vandewalle A.; Gougerot-Pocidalo M.A.; Lizard G.; Ogier-Denis E.; NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol Cell Biol  2004,24(24),10703-10717","journal-title":"Mol Cell Biol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","volume":"110","author":"Schr\u00f6der K.","year":"2012","unstructured":"Schr\u00f6der K.; Zhang M.; Benkhoff S.; Mieth A.; Pliquett R.; Kosowski J.; Kruse C.; Luedike P.; Michaelis U.R.; Weissmann N.; Dimmeler S.; Shah A.M.; Brandes R.P.; Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res  2012,110(9),1217-1225","journal-title":"Circ Res"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"F219","DOI":"10.1152\/ajprenal.00414.2002","volume":"285","author":"Gorin Y.","year":"2003","unstructured":"Gorin Y.; Ricono J.M.; Kim N.H.; Bhandari B.; Choudhury G.G.; Abboud H.E.; Nox4 mediates angiotensin II-induced activation of Akt\/protein kinase B in mesangial cells. Am J Physiol Renal Physiol  2003,285(2),F219-F229","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1128\/MCB.24.5.1844-1854.2004","volume":"24","author":"Mahadev K","year":"2004","unstructured":"Mahadev K; Motoshima H; Wu X; Ruddy JM; Arnold RS; Cheng G; The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of HO and plays an integral role in insulin signal transduction. Mol Cell Biol  2004,24(5),1844-54","journal-title":"Mol Cell Biol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cellsig.2005.05.025","volume":"18","author":"Lee Y.M.","year":"2006","unstructured":"Lee Y.M.; Kim B.J.; Chun Y.S.; So I.; Choi H.; Kim M.S.; Park J.W.; NOX4 as an oxygen sensor to regulate TASK-1 activity. Cell Signal  2006,18(4),499-507","journal-title":"Cell Signal"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"L661","DOI":"10.1152\/ajplung.00269.2005","volume":"290","author":"Sturrock A.","year":"2006","unstructured":"Sturrock A.; Cahill B.; Norman K.; Huecksteadt T.P.; Hill K.; Sanders K.; Karwande S.V.; Stringham J.C.; Bull D.A.; Gleich M.; Kennedy T.P.; Hoidal J.R.; Transforming growth factor-\u03b21 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol  2006,290(4),L661-L673","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1091\/mbc.e05-06-0532","volume":"17","author":"Li J.","year":"2006","unstructured":"Li J.; Stouffs M.; Serrander L.; Banfi B.; Bettiol E.; Charnay Y.; Steger K.; Krause K.H.; Jaconi M.E.; The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation. Mol Biol Cell  2006,17(9),3978-3988","journal-title":"Mol Biol Cell"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1111\/j.1365-2443.2005.00907.x","volume":"10","author":"Kuroda J.","year":"2005","unstructured":"Kuroda J.; Nakagawa K.; Yamasaki T.; Nakamura K.; Takeya R.; Kuribayashi F.; Imajoh-Ohmi S.; Igarashi K.; Shibata Y.; Sueishi K.; Sumimoto H.; The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells  2005,10(12),1139-1151","journal-title":"Genes Cells"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/01.ATV.0000251500.94478.18","volume":"27","author":"Clempus R.E.","year":"2007","unstructured":"Clempus R.E.; Sorescu D.; Dikalova A.E.; Pounkova L.; Jo P.; Sorescu G.P.; Lass\u00e8gue B.; Griendling K.K.; Griendling K.K.; Nox4 is required for maintenance of the differentiated vascular smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol  2007,27(1),42-48","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1161\/CIRCRESAHA.109.193722","volume":"105","author":"Lyle A.N.","year":"2009","unstructured":"Lyle A.N.; Deshpande N.N.; Taniyama Y.; Seidel-Rogol B.; Pounkova L.; Du P.; Papaharalambus C.; Lass\u00e8gue B.; Griendling K.K.; Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res  2009,105(3),249-259","journal-title":"Circ Res"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cellsig.2005.03.023","volume":"18","author":"Martyn K.D.","year":"2006","unstructured":"Martyn K.D.; Frederick L.M.; von Loehneysen K.; Dinauer M.C.; Knaus U.G.; Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal  2006,18(1),69-82","journal-title":"Cell Signal"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.freeradbiomed.2008.08.013","volume":"45","author":"Dikalov S.","year":"2008","unstructured":"Dikalov S.; Dikalova A.; Bikineyeva A.; Schmidt H.; Harrison D.; Griendling K.; Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med  2008,45(9),1340-1351","journal-title":"Free Radic Biol Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/sj.onc.1209406","volume":"25","author":"Mochizuki T.","year":"2006","unstructured":"Mochizuki T.; Furuta S.; Mitsushita J.; Shang W.H.; Ito M.; Yokoo Y.; Yamaura M.; Ishizone S.; Nakayama J.; Konagai A.; Hirose K.; Kiyosawa K.; Kamata T.; Inhibition of NADPH oxidase 4 activates apoptosis via the AKT\/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene  2006,25(26),3699-3707","journal-title":"Oncogene"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1161\/01.RES.0000187457.24338.3D","volume":"97","author":"Cucoranu I.","year":"2005","unstructured":"Cucoranu I.; Clempus R.; Dikalova A.; Phelan P.J.; Ariyan S.; Dikalov S.; Sorescu D.; NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts. Circ Res  2005,97(9),900-907","journal-title":"Circ Res"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0378-1119(01)00449-8","volume":"269","author":"Cheng G.","year":"2001","unstructured":"Cheng G.; Cao Z.; Xu X.; Meir E.G.V.; Lambeth J.D.; Homologs of gp91 phox : Cloning and tissue expression of Nox3, Nox4, and Nox5. Gene  2001,269(1-2),131-140","journal-title":"Gene"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.freeradbiomed.2006.10.054","volume":"42","author":"Belaiba R.","year":"2007","unstructured":"Belaiba R.; Djordjevic T.; Petry A.; Diemer K.; Bonello S.; Banfi B.; Hess J.; Pogrebniak A.; Bickel C.; G\u00f6rlach A.; NOX5 variants are functionally active in endothelial cells. Free Radic Biol Med  2007,42(4),446-459","journal-title":"Free Radic Biol Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.jacc.2008.07.063","volume":"52","author":"Guzik T.J.","year":"2008","unstructured":"Guzik T.J.; Chen W.; Gongora M.C.; Guzik B.; Lob H.E.; Mangalat D.; Hoch N.; Dikalov S.; Rudzinski P.; Kapelak B.; Sadowski J.; Harrison D.G.; Calcium-dependent NOX5 nicotinamide adenine dinucleotide phosphate oxidase contributes to vascular oxidative stress in human coronary artery disease. J Am Coll Cardiol  2008,52(22),1803-1809","journal-title":"J Am Coll Cardiol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/CIRCRESAHA.107.151076","volume":"101","author":"Miller F.J.","year":"2007","unstructured":"Miller F.J.; Filali M.; Huss G.J.; Stanic B.; Chamseddine A.; Barna T.J.; Lamb F.S.; Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3. Circ Res  2007,101(7),663-671","journal-title":"Circ Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.freeradbiomed.2009.07.022","volume":"47","author":"Cs\u00e1nyi G.","year":"2009","unstructured":"Cs\u00e1nyi G.; Taylor W.R.; Pagano P.J.; NOX and inflammation in the vascular adventitia. Free Radic Biol Med  2009,47(9),1254-1266","journal-title":"Free Radic Biol Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"22699","DOI":"10.1074\/jbc.274.32.22699","volume":"274","author":"Ushio-Fukai M.","year":"1999","unstructured":"Ushio-Fukai M.; Alexander R.W.; Akers M.; Yin Q.; Fujio Y.; Walsh K.; Griendling K.K.; Reactive oxygen species mediate the activation of Akt\/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem  1999,274(32),22699-22704","journal-title":"J Biol Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"C494","DOI":"10.1152\/ajpcell.00439.2003","volume":"287","author":"Taniyama Y.","year":"2004","unstructured":"Taniyama Y.; Ushio-Fukai M.; Hitomi H.; Rocic P.; Kingsley M.J.; Pfahnl C.; Weber D.S.; Alexander R.W.; Griendling K.K.; Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol  2004,287(2),C494-C499","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"29857","DOI":"10.1074\/jbc.M313320200","volume":"279","author":"Adachi T.","year":"2004","unstructured":"Adachi T.; Pimentel D.R.; Heibeck T.; Hou X.; Lee Y.J.; Jiang B.; Ido Y.; Cohen R.A.; S-glutathiolation of Ras mediates redox-sensitive signaling by angiotensin II in vascular smooth muscle cells. J Biol Chem  2004,279(28),29857-29862","journal-title":"J Biol Chem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/01.ATV.21.4.489","volume":"21","author":"Ushio-Fukai M.","year":"2001","unstructured":"Ushio-Fukai M.; Griendling K.K.; Becker P.L.; Hilenski L.; Halleran S.; Alexander R.W.; Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol  2001,21(4),489-495","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1161\/CIRCULATIONAHA.105.573709","volume":"112","author":"Matsuno K.","year":"2005","unstructured":"Matsuno K.; Yamada H.; Iwata K.; Jin D.; Katsuyama M.; Matsuki M.; Takai S.; Yamanishi K.; Miyazaki M.; Matsubara H.; Yabe-Nishimura C.; Nox1 is involved in angiotensin II-mediated hypertension: A study in Nox1-deficient mice. Circulation  2005,112(17),2677-2685","journal-title":"Circulation"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.febslet.2005.12.049","volume":"580","author":"Gavazzi G.","year":"2006","unstructured":"Gavazzi G.; Banfi B.; Deffert C.; Fiette L.; Schappi M.; Herrmann F.; Krause K.H.; Decreased blood pressure in NOX1-deficient mice. FEBS Lett  2006,580(2),497-504","journal-title":"FEBS Lett"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.redox.2016.11.002","volume":"11","author":"Siu K.L.","year":"2017","unstructured":"Siu K.L.; Li Q.; Zhang Y.; Guo J.; Youn J.Y.; Du J.; Cai H.; NOX isoforms in the development of abdominal aortic aneurysm. Redox Biol  2017,11,118-125","journal-title":"Redox Biol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00125-012-2557-6","volume":"55","author":"Youn J.Y.","year":"2012","unstructured":"Youn J.Y.; Gao L.; Cai H.; The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes. Diabetologia  2012,55(7),2069-2079","journal-title":"Diabetologia"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/FJC.0000000000001541","volume":"83","author":"Kumari K.","year":"2024","unstructured":"Kumari K.; Vishwakarma V.K.; Kumar K.; Mridha A.R.; Arava S.K.; Dhingra S.; Singh N.; Yadav H.N.; Effect of benidipine alone and in combination with bosentan and sildenafil in amelioration of pulmonary arterial hypertension in experimental model in rats. J Cardiovasc Pharmacol  2024,83(4),330-339","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.112.132159","volume":"127","author":"Gray S.P.","year":"2013","unstructured":"Gray S.P.; Di Marco E.; Okabe J.; Szyndralewiez C.; Heitz F.; Montezano A.C.; de Haan J.B.; Koulis C.; El-Osta A.; Andrews K.L.; Chin-Dusting J.P.F.; Touyz R.M.; Wingler K.; Cooper M.E.; Schmidt H.H.H.W.; Jandeleit-Dahm K.A.; NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis. Circulation  2013,127(18),1888-1902","journal-title":"Circulation"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1161\/hh0901.089987","volume":"88","author":"Wang H.D.","year":"2001","unstructured":"Wang H.D.; Xu S.; Johns D.G.; Du Y.; Quinn M.T.; Cayatte A.J.; Cohen R.A.; Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res  2001,88(9),947-953","journal-title":"Circ Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"H24","DOI":"10.1152\/ajpheart.00799.2009","volume":"298","author":"Judkins C.P.","year":"2010","unstructured":"Judkins C.P.; Diep H.; Broughton B.R.S.; Mast A.E.; Hooker E.U.; Miller A.A.; Selemidis S.; Dusting G.J.; Sobey C.G.; Drummond G.R.; Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE  mice. Am J Physiol Heart Circ Physiol  2010,298(1),H24-H32","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCRESAHA.111.300171","volume":"112","author":"Matsushima S.","year":"2013","unstructured":"Matsushima S.; Kuroda J.; Ago T.; Zhai P.; Ikeda Y.; Oka S.; Fong G.H.; Tian R.; Sadoshima J.; Broad suppression of NADPH oxidase activity exacerbates ischemia\/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1\u03b1 and upregulation of peroxisome proliferator-activated receptor-\u03b1. Circ Res  2013,112(8),1135-1149","journal-title":"Circ Res"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","volume":"93","author":"Byrne J.A.","year":"2003","unstructured":"Byrne J.A.; Grieve D.J.; Bendall J.K.; Li J.M.; Gove C.; Lambeth J.D.; Cave A.C.; Shah A.M.; Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res  2003,93(9),802-805","journal-title":"Circ Res"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/CS20130787","volume":"127","author":"Parajuli N.","year":"2014","unstructured":"Parajuli N.; Patel V.B.; Wang W.; Basu R.; Oudit G.Y.; Loss of NOX2 (gp91 phox ) prevents oxidative stress and progression to advanced heart failure. Clin Sci (Lond)  2014,127(5),331-340","journal-title":"Clin Sci (Lond)"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/j.jacc.2014.02.572","volume":"63","author":"Murdoch C.E.","year":"2014","unstructured":"Murdoch C.E.; Chaubey S.; Zeng L.; Yu B.; Ivetic A.; Walker S.J.; Vanhoutte D.; Heymans S.; Grieve D.J.; Cave A.C.; Brewer A.C.; Zhang M.; Shah A.M.; Endothelial NADPH oxidase-2 promotes interstitial cardiac fibrosis and diastolic dysfunction through proinflammatory effects and endothelial-mesenchymal transition. J Am Coll Cardiol  2014,63(24),2734-2741","journal-title":"J Am Coll Cardiol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yjmcc.2016.07.003","volume":"98","author":"Sirker A.","year":"2016","unstructured":"Sirker A.; Murdoch C.E.; Protti A.; Sawyer G.J.; Santos C.X.C.; Martin D.; Zhang X.; Brewer A.C.; Zhang M.; Shah A.M.; Cell-specific effects of Nox2 on the acute and chronic response to myocardial infarction. J Mol Cell Cardiol  2016,98,11-17","journal-title":"J Mol Cell Cardiol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/01.ATV.0000154279.98244.eb","volume":"25","author":"Djordjevic T.","year":"2005","unstructured":"Djordjevic T.; BelAiba R.S.; Bonello S.; Pfeilschifter J.; Hess J.; G\u00f6rlach A.; Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol  2005,25(3),519-525","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.acvd.2017.03.011","volume":"111","author":"Bouabout G.","year":"2018","unstructured":"Bouabout G.; Ayme-Dietrich E.; Jacob H.; Champy M.F.; Birling M.C.; Pavlovic G.; Madeira L.; Fertak L.E.; Petit-Demouli\u00e8re B.; Sorg T.; Herault Y.; Mudgett J.; Monassier L.; Nox4 genetic inhibition in experimental hypertension and metabolic syndrome. Arch Cardiovasc Dis  2018,111(1),41-52","journal-title":"Arch Cardiovasc Dis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1161\/HYPERTENSIONAHA.115.06280","volume":"67","author":"Cowley A.W.","year":"2016","unstructured":"Cowley A.W.; Yang C.; Zheleznova N.N.; Staruschenko A.; Kurth T.; Rein L.; Kumar V.; Sadovnikov K.; Dayton A.; Hoffman M.; Ryan R.P.; Skelton M.M.; Salehpour F.; Ranji M.; Geurts A.; Evidence of the importance of Nox4 in production of hypertension in dahl salt-sensitive rats. Hypertension  2016,67(2),440-450","journal-title":"Hypertension"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/jpp\/rgad043","volume":"75","author":"Vishwakarma V.K.","year":"2023","unstructured":"Vishwakarma V.K.; Shah S.; Kaur T.; Singh A.P.; Arava S.K.; Kumar N.; Yadav R.K.; Yadav S.; Arora T.; Yadav H.N.; Effect of vinpocetine alone and in combination with enalapril in experimental model of diabetic cardiomyopathy in rats: Possible involvement of PDE-1\/TGF-\u03b2\/ Smad 2\/3 signalling pathways. J Pharm Pharmacol  2023,75(9),1198-1211","journal-title":"J Pharm Pharmacol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/ATVBAHA.115.307012","volume":"36","author":"Gray S.P.","year":"2016","unstructured":"Gray S.P.; Di Marco E.; Kennedy K.; Chew P.; Okabe J.; El-Osta A.; Calkin A.C.; Biessen E.A.L.; Touyz R.M.; Cooper M.E.; Schmidt H.H.H.W.; Jandeleit-Dahm K.A.M.; Reactive oxygen species can provide atheroprotection via NOX4-dependent inhibition of inflammation and vascular remodeling. Arterioscler Thromb Vasc Biol  2016,36(2),295-307","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCRESAHA.112.279760","volume":"112","author":"Matsushima S.","year":"2013","unstructured":"Matsushima S.; Kuroda J.; Ago T.; Zhai P.; Park J.Y.; Xie L.H.; Tian B.; Sadoshima J.; Increased oxidative stress in the nucleus caused by Nox4 mediates oxidation of HDAC4 and cardiac hypertrophy. Circ Res  2013,112(4),651-663","journal-title":"Circ Res"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"18121","DOI":"10.1073\/pnas.1009700107","volume":"107","author":"Zhang M.","year":"2010","unstructured":"Zhang M.; Brewer A.C.; Schr\u00f6der K.; Santos C.X.C.; Grieve D.J.; Wang M.; Anilkumar N.; Yu B.; Dong X.; Walker S.J.; Brandes R.P.; Shah A.M.; NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc Natl Acad Sci USA  2010,107(42),18121-18126","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.yjmcc.2014.07.005","volume":"78","author":"Siu K.L.","year":"2015","unstructured":"Siu K.L.; Lotz C.; Ping P.; Cai H.; Netrin-1 abrogates ischemia\/reperfusion-induced cardiac mitochondrial dysfunction via nitric oxide-dependent attenuation of NOX4 activation and recoupling of NOS. J Mol Cell Cardiol  2015,78,174-185","journal-title":"J Mol Cell Cardiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/CIRCRESAHA.109.213116","volume":"106","author":"Ago T.","year":"2010","unstructured":"Ago T.; Kuroda J.; Pain J.; Fu C.; Li H.; Sadoshima J.; Upregulation of Nox4 by hypertrophic stimuli promotes apoptosis and mitochondrial dysfunction in cardiac myocytes. Circ Res  2010,106(7),1253-1264","journal-title":"Circ Res"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"C353","DOI":"10.1152\/ajpcell.00525.2002","volume":"285","author":"Brar S.S.","year":"2003","unstructured":"Brar S.S.; Corbin Z.; Kennedy T.P.; Hemendinger R.; Thornton L.; Bommarius B.; Arnold R.S.; Whorton A.R.; Sturrock A.B.; Huecksteadt T.P.; Quinn M.T.; Krenitsky K.; Ardie K.G.; Lambeth J.D.; Hoidal J.R.; NOX5 NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells. Am J Physiol Cell Physiol  2003,285(2),C353-C369","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1091\/mbc.e07-12-1223","volume":"19","author":"Kawahara T.","year":"2008","unstructured":"Kawahara T.; Lambeth J.D.; Phosphatidylinositol (4,5)-bisphosphate modulates Nox5 localization via an N-terminal polybasic region. Mol Biol Cell  2008,19(10),4020-4031","journal-title":"Mol Biol Cell"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1113\/EP086204","volume":"104","author":"Touyz R.M.","year":"2019","unstructured":"Touyz R.M.; Anagnostopoulou A.; Rios F.; Montezano A.C.; Camargo L.L.; NOX5: Molecular biology and pathophysiology. Exp Physiol  2019,104(5),605-616","journal-title":"Exp Physiol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1172\/JCI124283","volume":"129","author":"Casas A.I.","year":"2019","unstructured":"Casas A.I.; Kleikers P.W.M.; Geuss E.; Langhauser F.; Adler T.; Busch D.H.; Gailus-Durner V.; de Angelis M.H.; Egea J.; Lopez M.G.; Kleinschnitz C.; Schmidt H.H.H.W.; Calcium-dependent blood-brain barrier breakdown by NOX5 limits postreperfusion benefit in stroke. J Clin Invest  2019,129(4),1772-1778","journal-title":"J Clin Invest"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.2337\/db16-1585","volume":"66","author":"Jha J.C.","year":"2017","unstructured":"Jha J.C.; Banal C.; Okabe J.; Gray S.P.; Hettige T.; Chow B.S.M.; Thallas-Bonke V.; De Vos L.; Holterman C.E.; Coughlan M.T.; Power D.A.; Skene A.; Ekinci E.I.; Cooper M.E.; Touyz R.M.; Kennedy C.R.; Jandeleit-Dahm K.; NADPH oxidase Nox5 accelerates renal injury in diabetic nephropathy. Diabetes  2017,66(10),2691-2703","journal-title":"Diabetes"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"e009388","DOI":"10.1161\/JAHA.118.009388","volume":"7","author":"Montezano A.C.","year":"2018","unstructured":"Montezano A.C.; De Lucca Camargo L.; Persson P.; Rios F.J.; Harvey A.P.; Anagnostopoulou A.; Palacios R.; Gandara A.C.P.; Alves-Lopes R.; Neves K.B.; Dulak-Lis M.; Holterman C.E.; de Oliveira P.L.; Graham D.; Kennedy C.; Touyz R.M.; NADPH oxidase 5 is a pro-contractile Nox isoform and a point of cross-talk for calcium and redox signaling-implications in vascular function. J Am Heart Assoc  2018,7(12),e009388","journal-title":"J Am Heart Assoc"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.3390\/ijerph10093886","volume":"10","author":"Valavanidis A.","year":"2013","unstructured":"Valavanidis A.; Vlachogianni T.; Fiotakis K.; Loridas S.; Pulmonary oxidative stress, inflammation and cancer: Respirable particulate matter, fibrous dusts and ozone as major causes of lung carcinogenesis through reactive oxygen species mechanisms. Int J Environ Res Public Health  2013,10(9),3886-3907","journal-title":"Int J Environ Res Public Health"},{"key":"ref=118","first-page":"84","volume":"53","author":"Chatterjee M","year":"2007","unstructured":"Chatterjee M; Saluja R; Kanneganti S; Chinta S; Dikshit M; Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats. Cell Mol Biol Noisy--Gd Fr  2007,53(1),84-93","journal-title":"Cell Mol Biol Noisy--Gd Fr"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"Pacher P.","year":"2007","unstructured":"Pacher P.; Beckman J.S.; Liaudet L.; Nitric oxide and peroxynitrite in health and disease. Physiol Rev  2007,87(1),315-424","journal-title":"Physiol Rev"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1152\/physrev.00018.2001","volume":"82","author":"Dr\u00f6ge W.","year":"2002","unstructured":"Dr\u00f6ge W.; Free radicals in the physiological control of cell function. Physiol Rev  2002,82(1),47-95","journal-title":"Physiol Rev"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc08-s245","volume":"31","author":"Ceriello A.","year":"2008","unstructured":"Ceriello A.; Possible role of oxidative stress in the pathogenesis of hypertension. Diabetes Care  2008,31(Suppl. 2),S181-S184","journal-title":"Diabetes Care"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"L2","DOI":"10.1152\/ajplung.00135.2005","volume":"290","author":"Liu J.Q.","year":"2006","unstructured":"Liu J.Q.; Zelko I.N.; Erbynn E.M.; Sham J.S.K.; Folz R.J.; Hypoxic pulmonary hypertension: Role of superoxide and NADPH oxidase (gp91  ). Am J Physiol Lung Cell Mol Physiol  2006,290(1),L2-L10","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"L489","DOI":"10.1152\/ajplung.90488.2008","volume":"296","author":"Ismail S.","year":"2009","unstructured":"Ismail S.; Sturrock A.; Wu P.; Cahill B.; Norman K.; Huecksteadt T.; Sanders K.; Kennedy T.; Hoidal J.; NOX4 mediates hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: The role of autocrine production of transforming growth factor-\u03b21 and insulin-like growth factor binding protein-3. Am J Physiol Lung Cell Mol Physiol  2009,296(3),L489-L499","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"L881","DOI":"10.1152\/ajplung.00047.2008","volume":"295","author":"Fike C.D.","year":"2008","unstructured":"Fike C.D.; Slaughter J.C.; Kaplowitz M.R.; Zhang Y.; Aschner J.L.; Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol  2008,295(5),L881-L888","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCRESAHA.107.148015","volume":"101","author":"Mittal M.","year":"2007","unstructured":"Mittal M.; Roth M.; K\u00f6nig P.; Hofmann S.; Dony E.; Goyal P.; Selbitz A.C.; Schermuly R.T.; Ghofrani H.A.; Kwapiszewska G.; Kummer W.; Klepetko W.; Hoda M.A.R.; Fink L.; H\u00e4nze J.; Seeger W.; Grimminger F.; Schmidt H.H.H.W.; Weissmann N.; Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res  2007,101(3),258-267","journal-title":"Circ Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1089\/ars.2007.1995","volume":"10","author":"Gupte S.A.","year":"2008","unstructured":"Gupte S.A.; Wolin M.S.; Oxidant and redox signaling in vascular oxygen sensing: Implications for systemic and pulmonary hypertension. Antioxid Redox Signal  2008,10(6),1137-1152","journal-title":"Antioxid Redox Signal"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1091\/mbc.e09-12-1003","volume":"21","author":"Diebold I.","year":"2010","unstructured":"Diebold I.; Petry A.; Hess J.; G\u00f6rlach A.; The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol Biol Cell  2010,21(12),2087-2096","journal-title":"Mol Biol Cell"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fphys.2012.00412","volume":"3","author":"Chen F.","year":"2012","unstructured":"Chen F.; Haigh S.; Barman S.; Fulton D.J.R.; From form to function: The role of Nox4 in the cardiovascular system. Front Physiol  2012,3,412","journal-title":"Front Physiol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1165\/rcmb.2008-0132OC","volume":"42","author":"Nisbet R.E.","year":"2010","unstructured":"Nisbet R.E.; Bland J.M.; Kleinhenz D.J.; Mitchell P.O.; Walp E.R.; Sutliff R.L.; Hart C.M.; Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model. Am J Respir Cell Mol Biol  2010,42(4),482-490","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"L559","DOI":"10.1152\/ajplung.00090.2010","volume":"299","author":"Lu X.","year":"2010","unstructured":"Lu X.; Murphy T.C.; Nanes M.S.; Hart C.M.; PPAR\u03b3 regulates hypoxia-induced Nox4 expression in human pulmonary artery smooth muscle cells through NF-\u03baB. Am J Physiol Lung Cell Mol Physiol  2010,299(4),L559-L566","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"Rajagopalan S.","year":"1996","unstructured":"Rajagopalan S.; Kurz S.; M\u00fcnzel T.; Tarpey M.; Freeman B.A.; Griendling K.K.; Harrison D.G.; Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest  1996,97(8),1916-1923","journal-title":"J Clin Invest"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"669","DOI":"10.26452\/ijrps.v12i1.4158","volume":"12","author":"Farogh Ahsan","year":"2021","unstructured":"Farogh Ahsan ; Arshiya Shamim ; Upadhyay P.K.; Srivastav R.K.; Ahsan F.; Shamim A.; Cramming the causative mechanism of glycogen synthase kinase-3\u03b2 mediated by ischemic preconditioning against ovariectomy challenged rat heart. Int J Res Pharmaceut Sci  2021,12(1),669-675","journal-title":"Int J Res Pharmaceut Sci"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/01.HYP.35.2.595","volume":"35","author":"Nakane H.","year":"2000","unstructured":"Nakane H.; Miller F.J.; Faraci F.M.; Toyoda K.; Heistad D.D.; Gene transfer of endothelial nitric oxide synthase reduces angiotensin II-induced endothelial dysfunction. Hypertension  2000,35(2),595-601","journal-title":"Hypertension"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1161\/01.HYP.32.3.488","volume":"32","author":"Zafari A.M.","year":"1998","unstructured":"Zafari A.M.; Ushio-Fukai M.; Akers M.; Yin Q.; Shah A.; Harrison D.G.; Taylor W.R.; Griendling K.K.; Role of NADH\/NADPH oxidase-derived HO in angiotensin II-induced vascular hypertrophy. Hypertension  1998,32(3),488-495","journal-title":"Hypertension"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/HYPERTENSIONAHA.109.149187","volume":"56","author":"Wind S.","year":"2010","unstructured":"Wind S.; Beuerlein K.; Armitage M.E.; Taye A.; Kumar A.H.S.; Janowitz D.; Neff C.; Shah A.M.; Wingler K.; Schmidt H.H.H.W.; Oxidative stress and endothelial dysfunction in aortas of aged spontaneously hypertensive rats by NOX1\/2 is reversed by NADPH oxidase inhibition. Hypertension  2010,56(3),490-497","journal-title":"Hypertension"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/CIRCULATIONAHA.105.538934","volume":"112","author":"Dikalova A.","year":"2005","unstructured":"Dikalova A.; Clempus R.; Lass\u00e8gue B.; Cheng G.; McCoy J.; Dikalov S.; Martin A.S.; Lyle A.; Weber D.S.; Weiss D.; Taylor W.R.; Schmidt H.H.H.W.; Owens G.K.; Lambeth J.D.; Griendling K.K.; Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation  2005,112(17),2668-2676","journal-title":"Circulation"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.107.089706","volume":"50","author":"Gavazzi G.","year":"2007","unstructured":"Gavazzi G.; Deffert C.; Trocme C.; Sch\u00e4ppi M.; Herrmann F.R.; Krause K.H.; NOX1 deficiency protects from aortic dissection in response to angiotensin II. Hypertension  2007,50(1),189-196","journal-title":"Hypertension"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"H7","DOI":"10.1152\/ajpheart.00637.2004","volume":"288","author":"Laude K.","year":"2005","unstructured":"Laude K.; Cai H.; Fink B.; Hoch N.; Weber D.S.; McCann L.; Kojda G.; Fukai T.; Schmidt H.H.H.W.; Dikalov S.; Ramasamy S.; Gamez G.; Griendling K.K.; Harrison D.G.; Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22 in mice. Am J Physiol Heart Circ Physiol  2005,288(1),H7-H12","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=139","doi-asserted-by":"publisher","DOI":"10.2174\/0125899775280160240122065607","volume":"16","author":"Upadhyay P.K.","year":"2024","unstructured":"Upadhyay P.K.; Thakur N.; Vishwakarma V.K.; Chaurasiya H.S.; Ansari T.M.; Modulation of angiotensin-II and angiotensin 1-7 levels influences cardiac function in myocardial ischemia-reperfusion injury. Curr Drug Res Rev  2024,16","journal-title":"Curr Drug Res Rev"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/01.HYP.0000032100.23772.98","volume":"40","author":"Landmesser U.","year":"2002","unstructured":"Landmesser U.; Cai H.; Dikalov S.; McCann L.; Hwang J.; Jo H.; Holland S.M.; Harrison D.G.; Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension  2002,40(4),511-515","journal-title":"Hypertension"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1172\/JCI200314172","volume":"111","author":"Landmesser U.","year":"2003","unstructured":"Landmesser U.; Dikalov S.; Price S.R.; McCann L.; Fukai T.; Holland S.M.; Mitch W.E.; Harrison D.G.; Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest  2003,111(8),1201-1209","journal-title":"J Clin Invest"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/diagnostics10100754","volume":"10","author":"Kamani C.H.","year":"2020","unstructured":"Kamani C.H.; Allenbach G.; Jreige M.; Pavon A.G.; Meyer M.; Testart N.; Firsova M.; Fernandes Vieira V.; Boughdad S.; Nicod Lalonde M.; Schaefer N.; Guery B.; Monney P.; Prior J.O.; Treglia G.; Diagnostic performance of F-FDG PET\/CT in native valve endocarditis: Systematic review and bivariate meta-analysis. Diagnostics (Basel)  2020,10(10),754","journal-title":"Diagnostics (Basel)"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"H673","DOI":"10.1152\/ajpheart.00242.2010","volume":"299","author":"Dikalova A.E.","year":"2010","unstructured":"Dikalova A.E.; G\u00f3ngora M.C.; Harrison D.G.; Lambeth J.D.; Dikalov S.; Griendling K.K.; Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol  2010,299(3),H673-H679","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/01.HYP.0000158845.49943.5e","volume":"45","author":"Touyz R.M.","year":"2005","unstructured":"Touyz R.M.; Mercure C.; He Y.; Javeshghani D.; Yao G.; Callera G.E.; Yogi A.; Lochard N.; Reudelhuber T.L.; Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase. Hypertension  2005,45(4),530-537","journal-title":"Hypertension"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/01.CIR.0000124223.00113.A4","volume":"109","author":"Jung O.","year":"2004","unstructured":"Jung O.; Schreiber J.G.; Geiger H.; Pedrazzini T.; Busse R.; Brandes R.P.; gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation  2004,109(14),1795-1801","journal-title":"Circulation"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1161\/ATVBAHA.110.219238","volume":"31","author":"Ray R.","year":"2011","unstructured":"Ray R.; Murdoch C.E.; Wang M.; Santos C.X.; Zhang M.; Alom-Ruiz S.; Anilkumar N.; Ouattara A.; Cave A.C.; Walker S.J.; Grieve D.J.; Charles R.L.; Eaton P.; Brewer A.C.; Shah A.M.; Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol  2011,31(6),1368-1376","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11906-011-0238-3","volume":"14","author":"Takac I.","year":"2012","unstructured":"Takac I.; Schr\u00f6der K.; Brandes R.P.; The Nox family of NADPH oxidases: Friend or foe of the vascular system? Curr Hypertens Rep  2012,14(1),70-78","journal-title":"Curr Hypertens Rep"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.7150\/ijbs.7502","volume":"9","author":"Rajendran P.","year":"2013","unstructured":"Rajendran P.; Rengarajan T.; Thangavel J.; Nishigaki Y.; Sakthisekaran D.; Sethi G.; Nishigaki I.; The vascular endothelium and human diseases. Int J Biol Sci  2013,9(10),1057-1069","journal-title":"Int J Biol Sci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"e1000479","DOI":"10.1371\/journal.pbio.1000479","volume":"8","author":"Kleinschnitz C.","year":"2010","unstructured":"Kleinschnitz C.; Grund H.; Wingler K.; Armitage M.E.; Jones E.; Mittal M.; Barit D.; Schwarz T.; Geis C.; Kraft P.; Barthel K.; Schuhmann M.K.; Herrmann A.M.; Meuth S.G.; Stoll G.; Meurer S.; Schrewe A.; Becker L.; Gailus-Durner V.; Fuchs H.; Klopstock T.; de Angelis M.H.; Jandeleit-Dahm K.; Shah A.M.; Weissmann N.; Schmidt H.H.H.W.; Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol  2010,8(9),e1000479","journal-title":"PLoS Biol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.107.103192","volume":"51","author":"Yogi A.","year":"2008","unstructured":"Yogi A.; Mercure C.; Touyz J.; Callera G.E.; Montezano A.C.I.; Aranha A.B.; Tostes R.C.; Reudelhuber T.; Touyz R.M.; Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension  2008,51(2),500-506","journal-title":"Hypertension"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00395-011-0190-z","volume":"106","author":"Sirker A.","year":"2011","unstructured":"Sirker A.; Zhang M.; Shah A.M.; NADPH oxidases in cardiovascular disease: Insights from in vivo models and clinical studies. Basic Res Cardiol  2011,106(5),735-747","journal-title":"Basic Res Cardiol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","volume":"110","author":"Lass\u00e8gue B.","year":"2012","unstructured":"Lass\u00e8gue B.; San Mart\u00edn A.; Griendling K.K.; Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res  2012,110(10),1364-1390","journal-title":"Circ Res"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/130315","volume":"2015","author":"Perrotta I.","year":"2015","unstructured":"Perrotta I.; Aquila S.; The role of oxidative stress and autophagy in atherosclerosis. Oxid Med Cell Longev  2015,2015,1-10","journal-title":"Oxid Med Cell Longev"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/ars.2008.2220","volume":"11","author":"Frey R.S.","year":"2009","unstructured":"Frey R.S.; Ushio-Fukai M.; Malik A.B.; NADPH oxidase-dependent signaling in endothelial cells: Role in physiology and pathophysiology. Antioxid Redox Signal  2009,11(4),791-810","journal-title":"Antioxid Redox Signal"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/antiox6020032","volume":"6","author":"Prieto-Bermejo R.","year":"2017","unstructured":"Prieto-Bermejo R.; Hern\u00e1ndez-Hern\u00e1ndez A.; The importance of NADPH oxidases and redox signaling in angiogenesis. Antioxidants  2017,6(2),32","journal-title":"Antioxidants"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/ATVBAHA.108.181925","volume":"29","author":"Lee M.Y.","year":"2009","unstructured":"Lee M.Y.; Martin A.S.; Mehta P.K.; Dikalova A.E.; Garrido A.M.; Datla S.R.; Lyons E.; Krause K.H.; Banfi B.; Lambeth J.D.; Lass\u00e8gue B.; Griendling K.K.; Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol  2009,29(4),480-487","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1161\/ATVBAHA.107.152629","volume":"27","author":"Vendrov A.E.","year":"2007","unstructured":"Vendrov A.E.; Hakim Z.S.; Madamanchi N.R.; Rojas M.; Madamanchi C.; Runge M.S.; Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Arterioscler Thromb Vasc Biol  2007,27(12),2714-2721","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","volume":"120","author":"F\u00f6rstermann U.","year":"2017","unstructured":"F\u00f6rstermann U.; Xia N.; Li H.; Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res  2017,120(4),713-735","journal-title":"Circ Res"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1297124","DOI":"10.3389\/fphar.2023.1297124","volume":"14","author":"Yang S.","year":"2023","unstructured":"Yang S.; Chen H.; Su W.; Luo Y.; Liao J.; Wang Y.; Xiong L.; Zhang C.; Li F.; Chen Z.S.; Wang T.; Protective effects of Salvianic acid A against multiple-organ ischemia-reperfusion injury: A review. Front Pharmacol  2023,14,1297124","journal-title":"Front Pharmacol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"13304","DOI":"10.1074\/jbc.M110.192138","volume":"286","author":"Takac I.","year":"2011","unstructured":"Takac I.; Schr\u00f6der K.; Zhang L.; Lardy B.; Anilkumar N.; Lambeth J.D.; Shah A.M.; Morel F.; Brandes R.P.; The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J Biol Chem  2011,286(15),13304-13313","journal-title":"J Biol Chem"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/ATVBAHA.116.307096","volume":"36","author":"Fulton D.J.R.","year":"2016","unstructured":"Fulton D.J.R.; Barman S.A.; Clarity on the isoform-specific roles of NADPH oxidases and NADPH oxidase-4 in atherosclerosis. Arterioscler Thromb Vasc Biol  2016,36(4),579-581","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.freeradbiomed.2016.07.013","volume":"97","author":"Di Marco E.","year":"2016","unstructured":"Di Marco E.; Gray S.P.; Kennedy K.; Szyndralewiez C.; Lyle A.N.; Lass\u00e8gue B.; Griendling K.K.; Cooper M.E.; Schmidt H.H.H.W.; Jandeleit-Dahm K.A.M.; NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis. Free Radic Biol Med  2016,97,556-567","journal-title":"Free Radic Biol Med"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/0271678X15606456","volume":"36","author":"Nishimura A.","year":"2016","unstructured":"Nishimura A.; Ago T.; Kuroda J.; Arimura K.; Tachibana M.; Nakamura K.; Wakisaka Y.; Sadoshima J.; Iihara K.; Kitazono T.; Detrimental role of pericyte Nox4 in the acute phase of brain ischemia. J Cereb Blood Flow Metab  2016,36(6),1143-1154","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/biomedicines8070206","volume":"8","author":"Poznyak A.V.","year":"2020","unstructured":"Poznyak A.V.; Grechko A.V.; Orekhova V.A.; Khotina V.; Ivanova E.A.; Orekhov A.N.; NADPH oxidases and their role in atherosclerosis. Biomedicines  2020,8(7),206","journal-title":"Biomedicines"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/antiox6040090","volume":"6","author":"Burtenshaw D.","year":"2017","unstructured":"Burtenshaw D.; Hakimjavadi R.; Redmond E.; Cahill P.; Nox, reactive oxygen species and regulation of vascular cell fate. Antioxidants  2017,6(4),90","journal-title":"Antioxidants"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/HJH.0000000000000801","volume":"34","author":"Aguado A.","year":"2016","unstructured":"Aguado A.; Fischer T.; Rodr\u00edguez C.; Manea A.; Mart\u00ednez-Gonz\u00e1lez J.; Touyz R.M.; Hernanz R.; Alonso M.J.; Dixon D.A.; Briones A.M.; Salaices M.; Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells. J Hypertens  2016,34(2),253-265","journal-title":"J Hypertens"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"H282","DOI":"10.1152\/ajpheart.00231.2012","volume":"303","author":"Valente A.J.","year":"2012","unstructured":"Valente A.J.; Yoshida T.; Murthy S.N.; Sakamuri S.S.V.P.; Katsuyama M.; Clark R.A.; Delafontaine P.; Chandrasekar B.; Angiotensin II enhances AT  -Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT , Nox1, and interleukin-18. Am J Physiol Heart Circ Physiol  2012,303(3),H282-H296","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.phrs.2016.10.015","volume":"114","author":"Garc\u00eda-Redondo A.B.","year":"2016","unstructured":"Garc\u00eda-Redondo A.B.; Aguado A.; Briones A.M.; Salaices M.; NADPH oxidases and vascular remodeling in cardiovascular diseases. Pharmacol Res  2016,114,110-120","journal-title":"Pharmacol Res"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.redox.2018.11.021","volume":"21","author":"Vendrov A.E.","year":"2019","unstructured":"Vendrov A.E.; Sumida A.; Canugovi C.; Lozhkin A.; Hayami T.; Madamanchi N.R.; Runge M.S.; NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis. Redox Biol  2019,21,101063","journal-title":"Redox Biol"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0167-5273(96)02854-9","volume":"58","author":"Maxwell S.R.J.","year":"1997","unstructured":"Maxwell S.R.J.; Lip G.Y.H.; Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol  1997,58(2),95-117","journal-title":"Int J Cardiol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1093\/bmb\/ldh025","volume":"70","author":"Eltzschig H.K.","year":"2004","unstructured":"Eltzschig H.K.; Collard C.D.; Vascular ischaemia and reperfusion injury. Br Med Bull  2004,70(1),71-86","journal-title":"Br Med Bull"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/jcp.56.3.194","volume":"56","author":"Krijnen P A J.","year":"2003","unstructured":"Krijnen P A J.; Meischl C.; Hack C.E.; Meijer C.J.; Visser C.A.; Roos D.; Niessen H.W.; Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol  2003,56(3),194-199","journal-title":"J Clin Pathol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1016\/j.bbadis.2018.08.002","volume":"1864","author":"Li Z.","year":"2018","unstructured":"Li Z.; Zhang X.; Liu S.; Zeng S.; Yu L.; Yang G.; Guo J.; Xu Y.; BRG1 regulates NOX gene transcription in endothelial cells and contributes to cardiac ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis  2018,1864(10),3477-3486","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"e000555","DOI":"10.1161\/JAHA.113.000555","volume":"3","author":"Yu Q.","year":"2014","unstructured":"Yu Q.; Lee C.F.; Wang W.; Karamanlidis G.; Kuroda J.; Matsushima S.; Sadoshima J.; Tian R.; Elimination of NADPH oxidase activity promotes reductive stress and sensitizes the heart to ischemic injury. J Am Heart Assoc  2014,3(1),e000555","journal-title":"J Am Heart Assoc"},{"key":"ref=175","first-page":"7543","volume":"1666","author":"Narravula S","year":"2001","unstructured":"Narravula S; Colgan SP; Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. J Immunol Baltim Md 1950  2001,1666(12),7543-8","journal-title":"J Immunol Baltim Md 1950"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2174\/138920112798868782","volume":"13","author":"Braunersreuther V.","year":"2012","unstructured":"Braunersreuther V.; Jaquet V.; Reactive oxygen species in myocardial reperfusion injury: From physiopathology to therapeutic approaches. Curr Pharm Biotechnol  2012,13(1),97-114","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1161\/CIRCULATIONAHA.107.725481","volume":"117","author":"Moens A.L.","year":"2008","unstructured":"Moens A.L.; Champion H.C.; Claeys M.J.; Tavazzi B.; Kaminski P.M.; Wolin M.S.; Borgonjon D.J.; Van Nassauw L.; Haile A.; Zviman M.; Bedja D.; Wuyts F.L.; Elsaesser R.S.; Cos P.; Gabrielson K.L.; Lazzarino G.; Paolocci N.; Timmermans J.P.; Vrints C.J.; Kass D.A.; High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury. Circulation  2008,117(14),1810-1819","journal-title":"Circulation"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI200111927","volume":"108","author":"Barry-Lane P.A.","year":"2001","unstructured":"Barry-Lane P.A.; Patterson C.; van der Merwe M.; Hu Z.; Holland S.M.; Yeh E.T.H.; Runge M.S.; p47phox is required for atherosclerotic lesion progression in ApoE\u2013\/\u2013 mice. J Clin Invest  2001,108(10),1513-1522","journal-title":"J Clin Invest"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/S0891-5849(01)00727-4","volume":"31","author":"Wingler K.","year":"2001","unstructured":"Wingler K.; W\u00fcnsch S.; Kreutz R.; Rothermund L.; Paul M.; Schmidt H.H.H.W.; Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med  2001,31(11),1456-1464","journal-title":"Free Radic Biol Med"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1161\/01.RES.0000263381.83835.7b","volume":"100","author":"Bendall J.K.","year":"2007","unstructured":"Bendall J.K.; Rinze R.; Adlam D.; Tatham A.L.; de Bono J.; Channon K.M.; Volpi E.; Channon K.M.; Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: Studies in endothelial-targeted Nox2 transgenic mice. Circ Res  2007,100(7),1016-1025","journal-title":"Circ Res"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/cvr\/cvs026","volume":"94","author":"Douglas G.","year":"2012","unstructured":"Douglas G.; Bendall J.K.; Crabtree M.J.; Tatham A.L.; Carter E.E.; Hale A.B.; Channon K.M.; Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE\u2212\/\u2212 mice. Cardiovasc Res  2012,94(1),20-29","journal-title":"Cardiovasc Res"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"15565","DOI":"10.1073\/pnas.1002178107","volume":"107","author":"Kuroda J.","year":"2010","unstructured":"Kuroda J.; Ago T.; Matsushima S.; Zhai P.; Schneider M.D.; Sadoshima J.; NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc Natl Acad Sci USA  2010,107(35),15565-15570","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"23200","DOI":"10.1074\/jbc.M114.587196","volume":"289","author":"Zhang Y.","year":"2014","unstructured":"Zhang Y.; Shimizu H.; Siu K.L.; Mahajan A.; Chen J.N.; Cai H.; NADPH oxidase 4 induces cardiac arrhythmic phenotype in zebrafish. J Biol Chem  2014,289(33),23200-23208","journal-title":"J Biol Chem"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.1093\/eurheartj\/ehv460","volume":"36","author":"Sch\u00fcrmann C.","year":"2015","unstructured":"Sch\u00fcrmann C.; Rezende F.; Kruse C.; Yasar Y.; L\u00f6we O.; Fork C.; van de Sluis B.; Bremer R.; Weissmann N.; Shah A.M.; Jo H.; Brandes R.P.; Schr\u00f6der K.; The NADPH oxidase Nox4 has anti-atherosclerotic functions. Eur Heart J  2015,36(48),3447-3456","journal-title":"Eur Heart J"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.07.004","volume":"89","author":"Craige S.M.","year":"2015","unstructured":"Craige S.M.; Kant S.; Reif M.; Chen K.; Pei Y.; Angoff R.; Sugamura K.; Fitzgibbons T.; Keaney J.F.; Endothelial NADPH oxidase 4 protects ApoE-\/- mice from atherosclerotic lesions. Free Radic Biol Med  2015,89,1-7","journal-title":"Free Radic Biol Med"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0006-2952(88)90143-8","volume":"37","author":"Cooper J.M.","year":"1988","unstructured":"Cooper J.M.; Petty R.K.H.; Hayes D.J.; Morgan-Hughest J.A.; Clark J.B.; Chronic administration of the oral hypoglycaemic agent diphenyleneiodonium to rats. Biochem Pharmacol  1988,37(4),687-694","journal-title":"Biochem Pharmacol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"180","DOI":"10.5306\/wjco.v9.i8.180","volume":"9","author":"Qin S.","year":"2018","unstructured":"Qin S.; Schulte B.A.; Wang G.Y.; Role of senescence induction in cancer treatment. World J Clin Oncol  2018,9(8),180-187","journal-title":"World J Clin Oncol"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/cancers12010004","volume":"12","author":"Jeena M.T.","year":"2019","unstructured":"Jeena M.T.; Kim S.; Jin S.; Ryu J.H.; Recent progress in mitochondria-targeted drug and drug-free agents for cancer therapy. Cancers (Basel)  2019,12(1),4","journal-title":"Cancers (Basel)"},{"key":"ref=189","doi-asserted-by":"crossref","first-page":"298020","DOI":"10.1155\/2014\/298020","volume":"2014","author":"\u2019t Hart B.A.","year":"2014","unstructured":"\u2019t Hart B.A.; Copray S.; Philippens I.; Apocynin, a low molecular oral treatment for neurodegenerative disease. BioMed Res Int  2014,2014,298020","journal-title":"BioMed Res Int"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fphar.2019.00951","volume":"10","author":"Yang T.","year":"2019","unstructured":"Yang T.; Zang D.W.; Shan W.; Guo A.C.; Wu J.P.; Wang Y.J.; Wang Q.; Synthesis and evaluations of novel apocynin derivatives as anti-glioma agents. Front Pharmacol  2019,10,951","journal-title":"Front Pharmacol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1161\/HYPERTENSIONAHA.107.100214","volume":"51","author":"Heum\u00fcller S.","year":"2008","unstructured":"Heum\u00fcller S.; Wind S.; Barbosa-Sicard E.; Schmidt H.H.H.W.; Busse R.; Schr\u00f6der K.; Brandes R.P.; Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension  2008,51(2),211-217","journal-title":"Hypertension"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"558","DOI":"10.4168\/aair.2014.6.6.558","volume":"6","author":"Kim B.Y.","year":"2014","unstructured":"Kim B.Y.; Park H.R.; Shin J.H.; Kim S.W.; Cho J.H.; Park Y.J.; Kim S.W.; The serine protease inhibitor, 4-(2-aminoethyl) benzene sulfonyl fluoride hydrochloride, reduces allergic inflammation in a house dust mite allergic rhinitis mouse model. Allergy Asthma Immunol Res  2014,6(6),558-566","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/CIRCULATIONAHA.111.067801","volume":"125","author":"Qin F","year":"2012","unstructured":"Qin F; Siwik DA; Luptak I; Hou X; Wang L; Higuchi A; The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice. Circulation  2012,125(14),1757-64","journal-title":"Circulation"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Li Y.","year":"2011","unstructured":"Li Y.; Xu S.; Mihaylova M.M.; Zheng B.; Hou X.; Jiang B.; Park O.; Luo Z.; Lefai E.; Shyy J.Y.J.; Gao B.; Wierzbicki M.; Verbeuren T.J.; Shaw R.J.; Cohen R.A.; Zang M.; AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab  2011,13(4),376-388","journal-title":"Cell Metab"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1001\/archneurol.2010.199","volume":"67","author":"Willey J.Z.","year":"2010","unstructured":"Willey J.Z.; Elkind M.S.V.; 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the treatment of central nervous system diseases. Arch Neurol  2010,67(9),1062-1067","journal-title":"Arch Neurol"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1759720X10384307","volume":"2","author":"Kotyla P.","year":"2010","unstructured":"Kotyla P.; The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in modern rheumatology. Ther Adv Musculoskelet Dis  2010,2(5),257-269","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"e88520","DOI":"10.1371\/journal.pone.0088520","volume":"9","author":"Dierkes R.","year":"2014","unstructured":"Dierkes R.; Warnking K.; Liedmann S.; Seyer R.; Ludwig S.; Ehrhardt C.; The Rac1 inhibitor NSC23766 exerts anti-influenza virus properties by affecting the viral polymerase complex activity. PLoS One  2014,9(2),e88520","journal-title":"PLoS One"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1159\/000445666","volume":"39","author":"Veluthakal R.","year":"2016","unstructured":"Veluthakal R.; Sidarala V.; Kowluru A.; NSC23766, a known inhibitor of tiam1-rac1 signaling module, prevents the onset of type 1 diabetes in the NOD mouse model. Cell Physiol Biochem  2016,39(2),760-767","journal-title":"Cell Physiol Biochem"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"18852","DOI":"10.1038\/s41598-019-55189-5","volume":"9","author":"Lu W.J.","year":"2019","unstructured":"Lu W.J.; Li J.Y.; Chen R.J.; Huang L.T.; Lee T.Y.; Lin K.H.; VAS2870 and VAS3947 attenuate platelet activation and thrombus formation via a NOX-independent pathway downstream of PKC. Sci Rep  2019,9(1),18852","journal-title":"Sci Rep"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1538-7836.2011.04361.x","volume":"9","author":"Nieswandt B.","year":"2011","unstructured":"Nieswandt B.; Pleines I.; Bender M.; Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost  2011,9(Suppl. 1),92-104","journal-title":"J Thromb Haemost"},{"key":"ref=201","doi-asserted-by":"publisher","first-page":"s5","DOI":"10.1161\/ATVBAHA.107.158915","volume":"28","author":"May A.E.","year":"2008","unstructured":"May A.E.; Seizer P.; Gawaz M.; Platelets: Inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol  2008,28(3),s5-s10","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2007.02.027","volume":"43","author":"Stokes K.Y.","year":"2007","unstructured":"Stokes K.Y.; Russell J.M.; Jennings M.H.; Alexander J.S.; Granger D.N.; Platelet-associated NAD(P)H oxidase contributes to the thrombogenic phenotype induced by hypercholesterolemia. Free Radic Biol Med  2007,43(1),22-30","journal-title":"Free Radic Biol Med"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.3390\/molecules26133813","volume":"26","author":"Ardila-Leal L.D.","year":"2021","unstructured":"Ardila-Leal L.D.; Poutou-Pi\u00f1ales R.A.; Pedroza-Rodr\u00edguez A.M.; Quevedo-Hidalgo B.E.; A brief history of colour, the environmental impact of synthetic dyes and removal by using laccases. Molecules  2021,26(13),3813","journal-title":"Molecules"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/path.2975","volume":"225","author":"Dhiman M.","year":"2011","unstructured":"Dhiman M.; Garg N.J.; NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease. J Pathol  2011,225(4),583-596","journal-title":"J Pathol"},{"key":"ref=205","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1089\/ars.2013.5814","volume":"23","author":"Altenh\u00f6fer S.","year":"2015","unstructured":"Altenh\u00f6fer S.; Radermacher K.A.; Kleikers P.W.M.; Wingler K.; Schmidt H.H.H.W.; Evolution of NADPH oxidase inhibitors: Selectivity and mechanisms for target engagement. Antioxid Redox Signal  2015,23(5),406-427","journal-title":"Antioxid Redox Signal"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neuropharm.2018.09.039","volume":"143","author":"Huang X.","year":"2018","unstructured":"Huang X.; Xiaokaiti Y.; Yang J.; Pan J.; Li Z.; Luria V.; Li Y.; Song G.; Zhu X.; Zhang H.T.; O\u2019Donnell J.M.; Xu Y.; Inhibition of phosphodiesterase 2 reverses gp91phox oxidase-mediated depression- and anxiety-like behavior. Neuropharmacology  2018,143,176-185","journal-title":"Neuropharmacology"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1517\/13543776.2011.584870","volume":"21","author":"Kim J.A.","year":"2011","unstructured":"Kim J.A.; Neupane G.P.; Lee E.S.; Jeong B.S.; Park B.C.; Thapa P.; NADPH oxidase inhibitors: A patent review. Expert Opin Ther Pat  2011,21(8),1147-1158","journal-title":"Expert Opin Ther Pat"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1089\/ars.2014.5862","volume":"23","author":"Diebold B.A.","year":"2015","unstructured":"Diebold B.A.; Smith S.M.E.; Li Y.; Lambeth J.D.; NOX2 as a target for drug development: Indications, possible complications, and progress. Antioxid Redox Signal  2015,23(5),375-405","journal-title":"Antioxid Redox Signal"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5099\/aj160300208","volume":"8","author":"Chen Q.","year":"2016","unstructured":"Chen Q.; Devine I.; Walker S.; Pham H.; Ondrasik R.; Patel H.; Chau W.; Parker C.W.; Bartol K.D.; Riahi S.; Mittal A.; Barsotti R.; Young L.; Nox2ds-tat, a peptide inhibitor of NADPH oxidase, exerts cardioprotective effects by attenuating reactive oxygen species during ischemia\/reperfusion injury. Am J Biomed Sci  2016,8(3),208-227","journal-title":"Am J Biomed Sci"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"36437","DOI":"10.1074\/jbc.M113.521344","volume":"288","author":"Ranayhossaini D.J.","year":"2013","unstructured":"Ranayhossaini D.J.; Rodriguez A.I.; Sahoo S.; Chen B.B.; Mallampalli R.K.; Kelley E.E.; Csanyi G.; Gladwin M.T.; Romero G.; Pagano P.J.; Selective recapitulation of conserved and nonconserved regions of putative NOXA1 protein activation domain confers isoform-specific inhibition of Nox1 oxidase and attenuation of endothelial cell migration. J Biol Chem  2013,288(51),36437-36450","journal-title":"J Biol Chem"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s00125-017-4215-5","volume":"60","author":"Gray S.P.","year":"2017","unstructured":"Gray S.P.; Jha J.C.; Kennedy K.; van Bommel E.; Chew P.; Szyndralewiez C.; Touyz R.M.; Schmidt H.H.H.W.; Cooper M.E.; Jandeleit-Dahm K.A.M.; Combined NOX1\/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease. Diabetologia  2017,60(5),927-937","journal-title":"Diabetologia"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1089\/ars.2020.8047","volume":"33","author":"Urner S.","year":"2020","unstructured":"Urner S.; Ho F.; Jha J.C.; Ziegler D.; Jandeleit-Dahm K.; NADPH oxidase inhibition: Preclinical and clinical studies in diabetic complications. Antioxid Redox Signal  2020,33(6),415-434","journal-title":"Antioxid Redox Signal"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coi.2003.12.001","volume":"16","author":"Babior B.M.","year":"2004","unstructured":"Babior B.M.; NADPH oxidase. Curr Opin Immunol  2004,16(1),42-47","journal-title":"Curr Opin Immunol"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2174\/09298673113209990179","volume":"21","author":"Schildknecht S.","year":"2013","unstructured":"Schildknecht S.; Weber A.; Gerding H.; Pape R.; Robotta M.; Drescher M.; Marquardt A.; Daiber A.; Ferger B.; Leist M.; The NOX1\/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite. Curr Med Chem  2013,21(3),365-376","journal-title":"Curr Med Chem"},{"key":"ref=215","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/ars.2016.6664","volume":"25","author":"Jha J.C.","year":"2016","unstructured":"Jha J.C.; Banal C.; Chow B.S.M.; Cooper M.E.; Jandeleit-Dahm K.; Diabetes and kidney disease: Role of oxidative stress. Antioxid Redox Signal  2016,25(12),657-684","journal-title":"Antioxid Redox Signal"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"115052","DOI":"10.1016\/j.biopha.2023.115052","volume":"165","author":"Liao J.","year":"2023","unstructured":"Liao J.; Peng B.; Huang G.; Diao C.; Qin Y.; Hong Y.; Lin J.; Lin Y.; Jiang L.; Tang N.; Tang F.; Liang J.; Zhang J.; Yan Y.; Chen Q.; Zhou Z.; Shen C.; Huang W.; Huang K.; Lan Q.; Cui L.; Zhong H.; Xu F.; Li M.; Wei Y.; Lu P.; Zhang M.; Inhibition of NOX4 with GLX351322 alleviates acute ocular hypertension-induced retinal inflammation and injury by suppressing ROS mediated redox-sensitive factors activation. Biomed Pharmacother  2023,165,115052","journal-title":"Biomed Pharmacother"},{"key":"ref=217","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","volume":"17","author":"Zhang Y.","year":"2020","unstructured":"Zhang Y.; Murugesan P.; Huang K.; Cai H.; NADPH oxidases and oxidase crosstalk in cardiovascular diseases: Novel therapeutic targets. Nat Rev Cardiol  2020,17(3),170-194","journal-title":"Nat Rev Cardiol"},{"key":"ref=218","doi-asserted-by":"publisher","first-page":"e0204271","DOI":"10.1371\/journal.pone.0204271","volume":"13","author":"Wang X.","year":"2018","unstructured":"Wang X.; Elksnis A.; Wikstr\u00f6m P.; Walum E.; Welsh N.; Carlsson P.O.; The novel NADPH oxidase 4 selective inhibitor GLX7013114 counteracts human islet cell death in vitro. PLoS One  2018,13(9),e0204271","journal-title":"PLoS One"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"638","DOI":"10.2337\/db22-0515","volume":"72","author":"Dionysopoulou S.","year":"2023","unstructured":"Dionysopoulou S.; Wikstr\u00f6m P.; Bucolo C.; Romano G.L.; Micale V.; Svensson R.; Spyridakos D.; Mastrodimou N.; Georgakis S.; Verginis P.; Walum E.; Thermos K.; Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy. Diabetes  2023,72(5),638-652","journal-title":"Diabetes"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","volume":"363","author":"Kuhns D.B.","year":"2010","unstructured":"Kuhns D.B.; Alvord W.G.; Heller T.; Feld J.J.; Pike K.M.; Marciano B.E.; Uzel G.; DeRavin S.S.; Priel D.A.L.; Soule B.P.; Zarember K.A.; Malech H.L.; Holland S.M.; Gallin J.I.; Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med  2010,363(27),2600-2610","journal-title":"N Engl J Med"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/antiox12010092","volume":"12","author":"de Oliveira M.G.","year":"2022","unstructured":"de Oliveira M.G.; Monica F.Z.; Passos G.R.; Victorio J.A.; Davel A.P.; Oliveira A.L.L.; Parada C.A.; D\u2019Ancona C.A.L.; Hill W.G.; Antunes E.; Selective pharmacological inhibition of NOX2 by GSK2795039 improves bladder dysfunction in cyclophosphamide-induced cystitis in mice. Antioxidants  2022,12(1),92","journal-title":"Antioxidants"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"7029","DOI":"10.1074\/jbc.M115.702787","volume":"291","author":"Zielonka J.","year":"2016","unstructured":"Zielonka J.; Zielonka M.; VerPlank L.; Cheng G.; Hardy M.; Ouari O.; Ayhan M.M.; Podsiad\u0142y R.; Sikora A.; Lambeth J.D.; Kalyanaraman B.; Mitigation of NADPH oxidase 2 activity as a strategy to inhibit peroxynitrite formation. J Biol Chem  2016,291(13),7029-7044","journal-title":"J Biol Chem"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"114102","DOI":"10.1016\/j.jpba.2021.114102","volume":"201","author":"Padilha E.C.","year":"2021","unstructured":"Padilha E.C.; Shah P.; Rai G.; Xu X.; NOX2 inhibitor GSK2795039 metabolite identification towards drug optimization. J Pharm Biomed Anal  2021,201,114102","journal-title":"J Pharm Biomed Anal"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3892\/etm.2023.11893","volume":"25","author":"Noh M.H.","year":"2023","unstructured":"Noh M.H.; Lee D.K.; Kim Y.S.; Kim H.Y.; Moon S.H.; Han S.Y.; Hur D.Y.; APX-115A, a pan-NADPH oxidase inhibitor, reduces the degree and incidence rate of dry eye in the STZ-induced diabetic rat model. Exp Ther Med  2023,25(5),194","journal-title":"Exp Ther Med"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"74217","DOI":"10.18632\/oncotarget.18540","volume":"8","author":"Kwon G.","year":"2017","unstructured":"Kwon G.; Uddin M.J.; Lee G.; Jiang S.; Cho A.; Lee J.H.; Lee S.R.; Bae Y.S.; Moon S.H.; Lee S.J.; Cha D.R.; Ha H.; A novel pan-Nox inhibitor, APX-115, protects kidney injury in streptozotocin-induced diabetic mice: Possible role of peroxisomal and mitochondrial biogenesis. Oncotarget  2017,8(43),74217-74232","journal-title":"Oncotarget"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.23876\/j.krcp.21.269","volume":"41","author":"Lee H.E.","year":"2022","unstructured":"Lee H.E.; Shim S.; Choi Y.; Bae Y.S.; NADPH oxidase inhibitor development for diabetic nephropathy through water tank model. Kidney Res Clin Pract  2022,41(Suppl. 2),S89-S98","journal-title":"Kidney Res Clin Pract"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611308870240910115023","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/234249\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611308870240910115023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T09:55:09Z","timestamp":1738144509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/234249\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":226,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701611308870240910115023","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}